Intermolecular, Inc. (NASDAQ:IMI) is scheduled to be announcing its earnings results after the market closes on Thursday, November 2nd. Analysts expect the company to announce earnings of ($0.05) per share for the quarter.

Intermolecular, Inc. (NASDAQ:IMI) opened at 1.13 on Thursday. Intermolecular, Inc. has a 52 week low of $0.78 and a 52 week high of $1.20. The stock’s market cap is $56.00 million. The stock’s 50 day moving average is $1.02 and its 200 day moving average is $0.93.

TRADEMARK VIOLATION NOTICE: “Intermolecular, Inc. (IMI) Set to Announce Quarterly Earnings on Thursday” was first posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/10/26/intermolecular-inc-imi-set-to-announce-quarterly-earnings-on-thursday.html.

In other news, major shareholder Lloyd I. Miller III purchased 34,109 shares of the company’s stock in a transaction that occurred on Friday, September 1st. The shares were bought at an average price of $0.86 per share, for a total transaction of $29,333.74. Following the completion of the transaction, the insider now owns 70,368 shares in the company, valued at $60,516.48. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last 90 days, insiders have purchased 38,930 shares of company stock worth $33,480. 45.40% of the stock is owned by company insiders.

Separately, ValuEngine upgraded shares of Intermolecular from a “strong sell” rating to a “sell” rating in a research report on Monday, August 7th.

Intermolecular Company Profile

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Earnings History for Intermolecular (NASDAQ:IMI)

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with MarketBeat.com's FREE daily email newsletter.